Concepedia

Alice R. Lim

AR

5

Publications

556

Citations

5

H-Index

2001

Active since

Affiliations

Infinity Pharmaceuticals (United States)(Current)

Alice R. Lim is an author at Infinity Pharmaceuticals (United States) specializing in medicine, oncology, and tumor biology.

Top concepts

Publications per year

2001–2013

5

Publications

5

PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models

David G. Winkler, L. Kerrie, Jonathan P. DiNitto et al. · Chemistry & Biology · 2013 · 250 citations

, , +19

The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models

Emmanuel Normant, Guillermo Paez, Kip A. West et al. · Oncogene · 2011 · 144 citations

, , +8

Cd8− T Cell Transfectants That Express a High Affinity T Cell Receptor Exhibit Enhanced Peptide-Dependent Activation

Phillip D. Holler, Alice R. Lim, Bryan K. Cho et al. · The Journal of Experimental Medicine · 2001 · 95 citations · Full text

Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer

Maurizio Scaltriti, Violeta Serra, Emmanuel Normant et al. · Molecular Cancer Therapeutics · 2011 · 52 citations · Full text

, , +17

The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity<i>in vivo</i>

Mark Douglas, Alice R. Lim, James R. Porter et al. · Molecular Cancer Therapeutics · 2009 · 15 citations

Rows per page

1–5 of 5